छोड़कर सामग्री पर जाएँ

Latest News

Mankind Pharma hits 52-week high, JP Morgan starts coverage with #39;overweight#39; rating

Mankind Pharma hits 52-week high, JP Morgan starts coverage with #39;overweight#39; rating

The stock has delivered 37-percent returns since its listing in May 2023, the brokerage firm highlighted while adding that Mankind Pharma is one of the fastest growing domestic pharmaceutical companies with a leadership in value. Read More ​ The stock has… और पढ़ें »Mankind Pharma hits 52-week high, JP Morgan starts coverage with #39;overweight#39; rating

hi_INहिन्दी